These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8471420)

  • 61. Hydroxyurea (HU) in experimental hematology. I. Characterization of in vitro and in vivo effects on progenitor and transit cells.
    Benestad HB; Warhuus K; Reikvam A
    Exp Hematol; 1977 Sep; 5(5):408-14. PubMed ID: 902703
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
    J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
    Wadler S; Damle S; Haynes H; Kaleya R; Schechner R; Berkenblit R; Ladner RD; Murgo A
    J Clin Oncol; 1999 Jun; 17(6):1771-8. PubMed ID: 10561214
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases.
    Sgouros G; O'Donoghue JA; Larson SM; Macapinlac H; Larson JJ; Kemeny N
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1177-83. PubMed ID: 9719130
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
    Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
    Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hydroxyurea: a key player in cancer chemotherapy.
    Madaan K; Kaushik D; Verma T
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):19-29. PubMed ID: 22149429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
    Hamilton E; Dobbin J
    Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The toxicity of 125 IUdR in cultured mouse BP8 tumour cells.
    Porteous DD
    Br J Cancer; 1971 Sep; 25(3):594-7. PubMed ID: 5169169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 5-iodo-2'-deoxyuridine-protein conjugates: synthesis and enzymatic degradation.
    Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    Sel Cancer Ther; 1990; 6(1):1-13. PubMed ID: 2343200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of thymidine analogues on murine and human cells.
    Smellie SG; Parsons PG
    Aust J Exp Biol Med Sci; 1979 Dec; 57(6):563-73. PubMed ID: 162036
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
    de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
    J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The interaction between two radiosensitizers: 5-iododeoxyuridine and caffeine.
    Seo Y; Yan T; Schupp JE; Yamane K; Radivoyevitch T; Kinsella TJ
    Cancer Res; 2006 Jan; 66(1):490-8. PubMed ID: 16397265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The suicide technique in vitro for granulocytic progenitor cells (CFC) by application of hydroxyurea (HU) to low concentrations of human bone marrow cells.
    Morardet N; Charbord P; Parmentier C
    Biomedicine; 1979 Feb; 31(1):4-5. PubMed ID: 476273
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Iododeoxyuridine uptake and retention as a measure of tumor growth.
    Tjuvajev J; Muraki A; Ginos J; Berk J; Koutcher J; Ballon D; Beattie B; Finn R; Dahighian F; Blasberg R
    J Nucl Med; 1993 Jul; 34(7):1152-62. PubMed ID: 8315494
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.
    Mariani G; Collecchi P; Giuliani L; Baranowska-Kortylewicz J; Di Luca L; Meucci G; Viacava P; Van den Abbeele AD; Salvadori PA; Di Sacco S
    Ann N Y Acad Sci; 1993 Nov; 698():204-11. PubMed ID: 8279758
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potentiation of hydroxyurea cytotoxicity in human chronic myeloid leukemia cells by iron-chelating agent.
    Satyamoorthy K; Chitnis MP; Basrur VS; Advani SH
    Leuk Res; 1986; 10(11):1327-30. PubMed ID: 3099095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.